文献速递心律失常

MRI检测的脑部病变与房颤导管消融术后认知功能:AXAFA-AFNET 5随机试验

MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
PubMed 文献 · Circulation · 2022-02-09

AXAFA-AFNET 5试验的预设分析纳入674例阵发性房颤患者,随机接受不间断阿哌沙班或维生素K拮抗剂后进行首次消融。321例可分析MRI中84例(26.1%)检出急性脑缺血灶,但术后3个月MoCA评分与无病灶者相似;慢性白质损伤与较低MoCA评分相关,校正年龄和性别后不再显著。

要点

  • 不间断口服抗凝下消融后急性脑缺血灶常见,但未与3个月认知功能相关
  • 慢性白质损伤(Wahlund评分≥4分)与较低MoCA评分相关,校正年龄和性别后不显著
  • 较低MoCA评分仅与年龄较大相关,支持不间断口服抗凝下消融的安全性

核心结论

  • 首次消融后高分辨率DWI检出的急性脑缺血灶未与术后3个月认知功能相关。
  • 慢性白质损伤及急性缺血灶在不间断口服抗凝下首次消融后常见。
  • 术前及术后较低MoCA评分仅与年龄较大相关,提示不间断口服抗凝下消融安全。

研究设计与样本

  • AXAFA-AFNET 5试验的预设分析,随机674例房颤患者1:1接受不间断阿哌沙班或维生素K拮抗剂后首次消融。
  • 纳入欧洲和美国25个中心的 eligible 患者,消融后3至48小时行脑MRI(FLAIR和高分辨率DWI)。
  • 消融前3至6周及消融后3个月使用MoCA评估认知功能。

主要发现

  • 321例可分析MRI中84例(26.1%)高分辨率DWI检出至少1个急性脑病灶,阿哌沙班组44例(27.2%),维生素K拮抗剂组40例(24.8%),P=0.675。
  • 术后3个月MoCA评分在有或无急性脑病灶患者中相似(28 [IQR 26-29] vs 28 [IQR 26-29],P=0.948)。
  • FLAIR检出慢性白质损伤(Wahlund评分≥4分)130例(40.5%),与术前较低MoCA评分相关(27 [IQR 24-28] vs 27 [IQR 25-29],P=0.026)及术后3个月较低MoCA评分相关(27 [IQR 25-29] vs 28 [IQR 26-29],P=0.011)。
  • 慢性白质损伤与MoCA评分的关联在校正年龄和性别后不再显著。
  • 年龄与术前较低MoCA评分相关(相对风险1.02每10年 [95% CI 1.01-1.03])及术后3个月较低MoCA评分相关(相对风险1.02每10年 [95% CI 1.01-1.03])。

临床怎么用

  • 对于阵发性房颤首次消融患者,不间断口服抗凝下急性脑缺血灶虽常见,但未与短期认知下降相关。
  • 慢性白质损伤与较低认知评分相关,但主要由年龄和性别解释,临床解读需考虑这些因素。

局限性

  • 仅321例患者有可分析MRI,样本量有限。
  • 认知评估使用MoCA,随访仅3个月,不能反映长期认知变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to assess the prevalence of ischemic brain lesions detected by magnetic resonance imaging and their association with cognitive function 3 months after first-time ablation using continuous oral anticoagulation in patients with paroxysmal atrial fibrillation (AF). METHODS: We performed a prespecified analysis of the AXAFA-AFNET 5 trial (Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy), which randomized 674 patients with AF 1:1 to uninterrupted apixaban or vitamin K antagonist therapy before first-time ablation. Brain magnetic resonance imaging using fluid-attenuated inversion recovery and high-resolution diffusion-weighted imaging was obtained within 3 to 48 hours after AF ablation in all eligible patients enrolled in 25 study centers in Europe and the United States. Patients underwent cognitive assessment 3 to 6 weeks before ablation and 3 months after ablation using the Montreal Cognitive Assessment (MoCA). RESULTS: In 84 (26.1%) of 321 patients with analyzable magnetic resonance imaging, high-resolution diffusion-weighted imaging detected at least 1 acute brain lesion, including 44 (27.2%) patients treated with apixaban and 40 (24.8%) patients treated with vitamin K antagonist (P=0.675). Median MoCA score was similar in patients with or without acute brain lesions at 3 months after ablation (28 [interquartile range (IQR), 26-29] versus 28 [IQR, 26-29]; P=0.948). Cerebral chronic white matter damage (defined as Wahlund score ≥4 points) detected by fluid-attenuated inversion recovery was present in 130 (40.5%) patients and associated with lower median MoCA scores before ablation (27 [IQR, 24-28] versus 27 [IQR, 25-29]; P=0.026) and 3 months after ablation (27 [IQR, 25-29] versus 28 [IQR, 26-29]; P=0.011). This association was no longer significant when adjusted for age and sex. Age was associated with lower MoCA scores before ablation (relative risk, 1.02 per 10 years [95% CI, 1.01-1.03]) and 3 months after ablation (relative risk, 1.02 per 10 years [95% CI, 1.01-1.03]). CONCLUSIONS: Chronic white matter damage as well as acute ischemic lesions detected by brain magnetic resonance imaging were found frequently after first-time ablation for paroxysmal AF using uninterrupted oral anticoagulation. Acute ischemic brain lesions detected by high-resolution diffusion-weighted imaging were not associated with cognitive function at 3 months after ablation. Lower MoCA scores before and after ablation were associated only with older age, highlighting the safety of AF ablation on uninterrupted oral anticoagulation. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02227550.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Haeusler, Eichner, Heuschmann, et al. MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial. Circulation. 2022. PMID: 35135308. doi:10.1161/CIRCULATIONAHA.121.056320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。